Apremilast in people living with HIV with psoriasis vulgaris: A case report
Psoriasis is a chronic papulosquamous skin disease that involves immune-mediated cutaneous inflammation and keratinocyte hyperproliferation. The associated immunosuppression in people living with HIV (PLHIV) with psoriasis poses a challenge to the clinician as therapeutic options are limited. Until...
Saved in:
Main Authors: | Bela J Shah (Author), Deval Mistry (Author), Navin Chaudhary (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world efficacy and safety of apremilast monotherapy in the management of moderate-to-severe Psoriasis
by: Bela J Shah, et al.
Published: (2020) -
Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016) -
Apremilast for lithium-associated psoriasis
by: Joohyung Youh, et al.
Published: (2022) -
Treatment of erythrodermic psoriasis with apremilast
by: Olivia A. Gioe, MD, et al.
Published: (2021) -
A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris
by: Bela Shah, et al.
Published: (2023)